Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,331,491,343
+$54,328,267 QoQ
Shares Held
13,117,657
-2.2% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#29
of 4,676 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. JNJ ranks #2 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,331,491,343 | 13,117,657 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $3,277,163,076 | 13,406,820 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,360,405,677 | 11,405,681 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,476,272,228 | 13,354,936 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,709,440,215 | 11,191,098 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,923,716,456 | 11,599,834 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,725,343,051 | 11,930,183 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,664,311,616 | 10,269,725 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,611,558,252 | 11,025,987 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,580,209,414 | 9,989,313 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,344,187,498 | 8,575,906 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $931,512,241 | 5,980,817 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,149,603,099 | 6,945,403 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $975,774,600 | 6,295,320 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,161,734,476 | 6,576,476 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,156,974,158 | 7,082,359 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $657,631,759 | 3,704,759 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $533,571,111 | 3,010,614 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $632,580,586 | 3,697,788 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $724,425,851 | 4,485,609 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $911,020,586 | 5,530,051 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||